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Abstract
Background: Enhancement of tumor cell sensitivity may help facilitate a reduction in drug dosage using
conventional chemotherapies. Consequently, it is worthwhile to search for adjuvants with the potential of
increasing chemotherapeutic drug effectiveness and improving patient quality of life. Natural products are a very
good source of such adjuvants.
Methods: The biological activity of a fraction enriched in hydrolysable polyphenols (P2Et) obtained from
Caesalpinia spinosa was evaluated using the hematopoietic cell line K562. This fraction was tested alone or in
combination with the conventional chemotherapeutic drugs doxorubicin, vincristine, etoposide, camptothecin and
taxol. The parameters evaluated were mitochondrial depolarization, caspase 3 activation, chromatin condensation
and clonogenic activity.
Results: We found that the P2Et fraction induced mitochondrial depolarization, activated caspase 3, induced
chromatin condensation and decreased the clonogenic capacity of the K562 cell line. When the P2Et fraction was
used in combination with chemotherapeutic drugs at sub-lethal concentrations, a fourfold reduction in doxorubicin
inhibitory concentration 50 (IC50) was seen in the K562 cell line. This finding suggested that P2Et fraction activity is
specific for the molecular target of doxorubicin.
Conclusions: Our results suggest that a natural fraction extracted from Caesalpinia spinosa in combination with
conventional chemotherapy in combination with natural products on leukemia cells may increase therapeutic
effectiveness in relation to leukemia.
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Background
Caesalpinia spinosa is a shrub commonly named divi-
divi. It is acknowledged to have antimicrobial and anti-
oxidant activity, and is traditionally known for its
antitumor activity [1]. An ethanol extract from the fruit
of C.spinosa h a sb e e np r o v e nt oh a v ea n t i m i c r o b i a l
activity against gram-positive and gram-negative bac-
teria, probably due to the presence of hydrolysable tan-
nins in the fruits [2]. Hydrolysable tannins are a group
of gallic acid esters associated with polyols (glucose, glu-
citol, shikimic acid, quinic acid and quercitol, among
others), where the galloyl groups can be further cross-
linked by etherification or oxidation to form complex
structures. The gallotannins (gallic acid esters) are the
simplest hydrolysable tannins, were 1,2,3,4,6-penta-O-
galloyl-b-D-glucose (pentagalloyl glucose [PGG]) is the
prototype and central compound of the biosynthetic
pathway [3]. The presence of PGG, as well as
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been reported in Caesalpinia species corresponding to
40% to 60% of the fruit composition, depending upon
their ecological habitat [4].
Gallic acid and its derivatives have proven selective
antitumor activities, such as: reduction in biochemical
markers associated with skin cancer [5]; cell death
induction in several cancer cell lines, including leukemia
[6,7], murine myeloma [8] and squamous carcinoma [9].
In addition, a beverage containing epigallocatechin gal-
late (EGCG) has been reported to promote tumor
regression in patients with low-grade lymphomas [10].
Galloylquinic derivatives, such as 4,5-di-O-galloylquinic
acid, have shown moderate cytotoxicity against mela-
noma cells (RPMI-7951) but not in other cell lines [11].
Extensive studies have been carried out on PGG and
have demonstrated that this compound has a number
biological activities related to cancer therapy and pre-
vention, such as antiangiogenic, antiproliferative, anti-
inflammatory and antioxidant [3]. However, there are
limited studies supporting the use of polyphenols in the
treatment of hematological malignancies, and even
fewer involving hydrolysable polyphenols. In the present
study, taking into account that polyphenol antioxidant
activity has been clearly implicated in the control of
these malignancies [12], and that C.spinosa has a high
content of polyphenols and is widely distributed in our
country, we have evaluated the anti-tumor activity of C.
spinosa pod extracts and complex fractions using the
erythroleukemia cell line (K652) as a model of hemato-
logical malignancy.
Methods
Plant material
C.spinosa pods were collected in Villa de Leyva, Boyacá,
Colombia in March 2007 and identified by Luis Carlos
Jiménez from the Colombian National Herbarium; vou-
cher specimen number COL 523714.
Plant extraction and purification
Three kg of fresh pods from C.spinosa were dried under
airflow in a solar oven at 35°C and ground down to
obtain 1.8 kg of plant material. Subsequently the plant
material was extracted with ethanol (96%, 10 L) in a
recirculating percolator (twice per day) over a period of
10 days. The ethanol crude extract (80 g) was concen-
trated under vacuum, trapped on silica gel and excess
humidity removed at 25°C. Afterwards, the ethanol
extract was fractionated with the following solvents: pet-
roleum ether (1.5 L); chloroform (2 L); ethyl acetate (2
L); ethanol (2 L) and water (2 L) (aqueous fraction).
From the ethyl acetate fraction we obtained an abundant
precipitate which we named (P2Et). This corresponded
to 2.78% of the ethanol extract and a supernatant which
w en a m e d( S 2 E t )c o r r e s p o n d e dt o1 . 1 1 % .T h eP 2 E t ,
S2Et and aqueous fractions were selected for biological
testing based on their cytotoxic activity. The extraction
protocol was performed three times and the chromato-
graphic profiles of the components were verified.
The quality control carried out on the P2Et fraction
gave the following results: foreign matter less than 2%;
total ash less than 8%; ash that was insoluble in hydro-
chloric acid less than 1%; no evidence of heavy metals
and pesticides. These result met the British Herbal Phar-
macopoeia quality parameters.
Phytochemical characterization
Fraction characterization was determined by means of
standard phytochemical tests. In the total ethanol
extract the presence of alkaloids or nitrogen compounds
were not identified using Dragenddorff, Valser, Reineck-
ate and Mayer’s reagents. The Shinoda test (Mg in HCl)
was positive suggesting the presence of flavanones, flava-
nonols, flavones, flavonols or isoflavones. Hydrogen per-
oxide evidenced the presence of naphthoquinones and/
or anthraquinones. The presence of steroids was
demonstrated using Liebermann Burchard reagent. Low
concentrations of steroidal saponins and/or triterpenoids
were detected using hemolysis and foam tests. In order
to assess the presence of anthraquinone glycosides,
Borntrager’s reaction (treatment with ammonia solution)
was used. The presence of tannins was verified using
ferric chloride solution, gelatin and lead acetate [13].
P2Et, S2Et and aqueous fractions exhibited the presence
of leucoanthocyanidins, the absence of quinones and a
significant tannin content, especially in P2Et fraction.
Thin layer chromatography (TLC)
Chromatographic analysis was carried out on TLC alu-
minum sheets (10 × 5 cm) (Merck) silica gel 60 F 254.
Three solvent systems were used: Petroleum ether -
ethyl acetate - formic acid (40:60:1); chloroform - ethyl
acetate - acetic acid (50:50:1); and toluene - acetonitrile
- formic acid (70:30:1). After basic hydrolysis, the P2Et
and S2Et fractions were dissolved in methanol (1%) and
detected using UV (254 nm), FeCl3 (10%) and vanillin-
sulfuric acid (VS)/110°C. Gallic acid was used as a posi-
tive control.
HPLC - PDA-MS
HPLC analysis was carried out in an Alliance 2795
(Waters
®, UK) with a PDA detector (996). A Sunfire
(Waters) column C18 - 2.1 × 150 mm × 5 μm was used,
with a flow rate of 0.25 ml/min and a linear gradient
from 95% solvent A (H2O + 1%CH3COOH) and 5% sol-
vent B (CH3CN) to 60% in solvent A and 40% in solvent
B, over a period of 25 min. The mass spectrum (MS)
analysis was carried out using a LCT (Micromass
®,U K )
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relative abundance was determined using quercetin as
an internal standard (0.0625 μg/μl). Runs were per-
formed in triplicate.
Tumor cell line and normal cells
The cell lines used as cancer cells were K562, a human
erythroleukemia and MCF7, a human breast adenocarci-
noma, from the American Type Culture Collection
(ATCC); and the cell lines used as normal cells were
human peripheral blood mononuclear cells (PBMC) and
human fibroblasts obtained from normal healthy donors
after informed consent was given. This project was
approved by the ethics committee (founded in 2002) of
the Science Faculty at a meeting on August 21, 2007.
The culture conditions under which the cell lines were
maintained have already been reported [14].
In vitro cytotoxicity assays
The cytotoxic effects of the fractions and conventional
chemotherapeutic drugs (doxorubicin, etoposide, vincris-
tine and taxol) were evaluated using normal and tumor
cells by means of trypan blue and the methylthiazol tet-
razolium (MTT) assay, as previously reported [14]. The
P2Et fraction was dissolve in ethanol and the corre-
sponding vehicle was used as a negative control.
Measurement of mitochondrial membrane potential
The cells were treated with different concentrations of
the P2Et fraction or valinomycin (positive control, 0.1
μg/ml) for 4, 8 and 12 h for K562 cells, and for 6, 12
and 24 h for MCF7 cells. The mitochondrial membrane
potential (MMP) was measured using JC-1 dye, as pre-
viously described [14].
Annexin V assay
Phosphatidylserine (PS) externalization was assessed by
flow cytometry using Annexin V-FITC (Molecular
Probes, Invitrogen Corp, Carlsbad, CA, USA)/PI (Sigma,
Saint Louis, MO, USA). K562 and MCF7 cells (3 × 10
5)
were treated with doxorubicin, ethanol or the P2Et frac-
tion for 48 h. After treatment, cells were suspended in
Annexin buffer (Hepes 100 mM, NaCl 140 mM, CaCl2
2.5 mM) and incubated with Annexin V-FITC for 8 min
at room temperature. Then the cells were incubated
with PI for 2 min at 4°C, acquired on a FACSAria I
(Becton Dickinson, New Jersey, USA) and analyzed with
FlowJo software (Tree Star Inc., Ashland, USA). Results
are expressed as the mean ± SE of three independent
experiments.
Caspase 3 assays
Caspase 3 activity was estimated using the caspase 3 col-
orimetric assay kit, which detects enzyme activity based
on the cleavage of Asp-Glu-Val-Asp (DEVD)-pNA
(R&D Systems Inc., Minneapolis, MN, USA). Briefly,
cells (2 × 10
5 cells/ml) were cultured using different
concentrations of the P2Et fraction and doxorubicin
(positive control) or ethanol (negative control) for 48 h.
After the cells were ice lysed for 10 min the enzyme
activity was measure on 96-well flat-bottom microplates
with 50 μl of supernatant. The supernatant was pre-
pared by centrifuging at 10,000 × g for 1 min (100-200
μg of total protein), and then adding 50 μl of reaction
buffer supplemented with 10 μl of DTT and 5 μl of cas-
pase 3 colorimetric substrate DEVD-pNA. Next cells
were incubated for 1 ± 2 h at 37°C and caspase-3 activ-
ity was measured at 405 nm on a spectrophotometer
(Multiskan Labsystem). The increase in caspase 3 activ-
ity was calculated relative to the absorbance value of the
negative control.
DNA fragmentation and cell cycle analysis
DAPI (4’,6-diamidino-2-phenylindole, Sigma) stained
cells were monitored under a microscope as previously
described [14]. Slides were mounted using prolong anti-
fade kit (Molecular Probes, Eugene, Oregon, USA) and
cells were analyzed under a fluorescence microscope
(Olympus, Japan). Cell cycle analysis was undertaken as
previously reported [14].
Clonogenic assays
The clonogenic assays were performed as previously
described [14]. Briefly, K562 human cells (2.5 × 10
5
cells/well) were plated (96-well plate) and treated with
t h eP 2 E tf r a c t i o na t4 0a n d2 0μg/ml, or with 15 and 6
μg/ml etoposide, or 0.2% ethanol (in PBS) and incubated
for 24 h under a humidified environment at 37°C and
5% CO2. After treatment cells were re-plated onto 0.5%
agar dishes (60 mm, 20,000 cells/dish), incubated for 14
days (37°C and 5% CO2) and stained with violet crystal
(0.4% in ethanol). Cell colonies with more than 50 cells
were counted. Treatments were performed in triplicate,
and results expressed as mean ± SE.
P2Et fraction adjuvant activity
P2Et fraction adjuvant activity was assessed using K562
and MCF7 cells in combination with the well-known
cancer treatment drugs doxorubicin, vincristine, taxol
and camptothecin. Cell viability was evaluated by means
of the MTT assay. K562 and MCF7 cells (5 × 10
3 cells/
well) were seeded in 96-well plates and treated for 6 h
with sublethal concentrations of the P2Et fraction (1.6
μg/ml, 27 fold less than the IC50 value for K562 cells
and 15.5 μg/ml for MCF7 cells); washed and incubated
in fresh medium with each drug for 48 h at 37°C in
humid atmosphere and 5% CO2. Sublethal concentra-
tions of the chemotherapeutic drugs had been previously
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viability percentage relative to the control (100 × Treat-
ment OD/Negative control OD).
Statistical analysis
Data is presented as the mean ± SE. The data were ana-
lyzed by one- and two-way ANOVA and differences
between control and treated groups were determined
using the Bonferroni and Tukey tests. Differences were
considered significant for p < 0.05 and were determined
using the GraphPad prism 5.0 software.
Results and discussion
TLC and HPLC-PDA-MS analyses
TLC analysis of the P2Et and S2Et fractions after hydro-
lysis revealed the presence of gallic acid visualized using
UV (254 nm), ferric chloride and vainillin-sulfuric acid
(VS) reagents (Figure 1A, B and 1C). Gallic acid reten-
tion (Rf) values in different solvent systems are shown
in Figure 1D. The values are in agreement with those
previously reported [15].
Chemical characterization of the most biological active
fraction, P2Et, was carried out. The presence of gallic
acid (after hydrolysis) was confirmed (data not shown)
using proton nuclear magnetic resonance (H-NMR)
spectroscopy. HPLC-PDA analysis revealed 17 peaks at
263 nm, and peaks having the highest absorbance dis-
play retention times of 3.32 and 3.78 min (Figure 1E).
The peak molecular weights were calculated by means
of mass spectrometry, and seven compounds were
found to match with the molecular weights of com-
pounds already published [4] for this species (Figure 1F
and 1G, and Table 1). Clifford et al. reported the pre-
sence of gallotannins, ellagitannins, and galloylquinic
acid tannins in C.spinosa fruits [4]. In summary, the
P2Et fraction was found to contain hydrolysable tannins
such as galloylquinic acid derivatives at high percen-
tages, and pentagalloylglucose and gallic acid-like com-
pounds (gallates) at lower percentages.
Morphological and cell viability changes in the K562
tumor cell line induced by fractions derived from
Caesalpinia spinosa
Assessment of changes in K562 cell viability was carried
out using trypan blue to select fractions derived from C.
spinosa that had potential antitumor activity. Antitumor
activity was found using the aqueous fraction at a con-
centration of 62.5 μg/ml, while the S2Et and P2Et frac-
tions showed antitumor activity at a concentration of
15.6 μg/ml (Figure 2A). Assessment of changes in the
appearance of intracellular vesicles, cell membrane mor-
phology, nuclear alterations and the presence of necrotic
cells were carried out by means of direct observation
using a light microscope, and compared with etoposide
activity as shown in Figure 2B.
In order to confirm cell viability the activity of mito-
chondria dehydrogenase was estimated using the MTT
assay. The aqueous fraction induced cytotoxicity at a
concentration of 62.5 μg/ml, while the S2Et and P2Et
fractions induced cytotoxicity at concentrations of 31.2
and 15.6 μg/ml, respectively (Figure 2C). The P2Et frac-
tion displayed significant cytotoxic activity in a dose-
dependent manner. This finding was in agreement with
those reported in previous studies on leukemia cells
using chemically related P2Et tannins. Alkyl gallates and
gallamides have been shown to exhibit cytotoxic activity
with regard to murine lymphocyte leukemia cells
(L1210) [6], and an acetone derived gallotannin-enriched
fraction extracted from Eugenia jambos species was
found to have a cytotoxic effect on promyelocytic leuke-
mia HL-60 cells [16]. The biological activity of tannins
has been widely documented [6,17], but reports related
to C. spinosa anti-tumoral activity are scarce. Gali-Muh-
tasib et al. found that hydrolysable tannins extracted
from the fruit of C. spinosa decreased the level of skin
cancer biochemical markers. In addition, there are
reports describing anti-inflammatory and anti-microbial
activity of tannins [5].
Additionally, the cytotoxic activity of C. spinosa frac-
tions was evaluated using gingival fibroblasts from the
oral mucosa or normal human mononuclear cells. The
S2Et and aqueous fractions did not show cytotoxic
activity with regard to the PHA-stimulated PBMCs or
fibroblast cells, and the P2Et fraction had a slight cyto-
toxic effect at a concentration of 125 μg/ml on fibro-
blasts (Figure 2D and 2E). The IC50 values are shown in
Table 2. However, it has been reported that 1-O-galloyl
castalagin, casuarinin and gallotannins extracted from
Eugenia jambos are cytotoxic to lymphocytes and to
normal hepatic cells [16,18]. The decreased toxicity to
normal cells and the specificity toward tumor cells was
probably due to interactions among the fraction com-
pounds. Evaluation of biological activity was continued
only in the case of the P2Et fraction due to its superior
biological results and the remarkable yield obtained dur-
ing the extraction procedures.
Induction of MMP loss, caspase 3 activation and DNA
fragmentation in the K562 cell line by the P2Et fraction
Cell death analysis may help envisage the possible uses
of the P2Et fraction in cancer treatment. Cytotoxic
drugs can induce apoptosis by means of the mitochon-
drial pathway, inferring with MMP loss, effector cas-
pases activation and DNA fragmentation [19]. In order
to determine if the P2Et fraction induces apoptosis and
changes in MMP, K562 cells were treated with the P2Et
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Page 4 of 10Figure 1 P2Et fraction thin layer chromatographic profile. (A) Solvent I: petroleum benzene - ethyl acetate - formic acid (40:60:1). (B) Solvent
II: chloroform - ethyl acetate - acetic acid (50:50:1). (C) Solvent III: Toluene - acetonitrile - formic acid (70:30:1). Lane 1: P2Et fraction basic
hydrolysis products. Lane 2: S2Et fraction basic hydrolysis products. TLC visualization with UV, 254 nm, ferric chloride (FeCl3) and vanillin/sulfuric
acid (VS) sprays. Gallic acid is a positive control. (D) Gallic acid Rf values in different solvent systems. (E) HPLC chromatogram at 263 nm. (F) MS
spectrum positive mode. (G) MS spectrum negative mode.
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Page 5 of 10fraction for 4, 8 and 12 h. Results showed that MMP
loss occurred in a dose-dependent manner, starting at 4
h and continuing over a 12 h period (Figure 3A). Conse-
quently, effector caspases activation may occur, which in
fact was demonstrated in K562 cells after 48 h of treat-
ment (Figure 3B). Finally, only a low percentage of cells
displayed PS externalization (Figure 3C), suggesting that
the loss in MMP was not followed by PS externalization;
this was probably because the cells entered a different
cell death process. Nonetheless, an early loss of MMP
seems to be followed by DNA fragmentation (Figure 3D
and 3E).
Loss of MMP induced by the P2Et fraction can be seen
as an early apoptotic event that lasts for 12 h. These
results correlated with previously described activity for
alkyl gallates and gallamides having 8 to 12 carbon chains
[6,18]. In addition, the P2Et fraction induced caspase 3
activation and DNA fragmentation, suggesting that after
MMP loss, apoptotic cell death may be ongoing. How-
ever, since evidence of PS externalization was not found
(Figure 3D), the decrease in long-term viability might be
mediated by other cell death mechanisms.
Effect of the P2Et fraction on tumor cell clonogenic
capacity
Clonogenic ability is considered to be a gold standard
test for determining the antitumor activity of extracted
plant fractions as well as isolated compounds [20]. K562
cells were treated with the P2Et fraction for 6 h and
agar cultured for 14 days. Experimental data showed a
significant decrease in the clonogenic ability of treated
tumor cells as compared with the negative control (Fig-
ure 4). Indeed, a decrease in clonogenic ability also
implies a decrease in long-term viability. Similar results
were reported for PGG, a compound also present in the
P2Et fraction, which is able to induce caspase-mediated
apoptosis in the HL-60 cell line [21].
Table 1 Compounds in the P2Et fraction.
MS (m/
z)
Reported
m/z
Possible compounds Relative abundance*
(%)
344 344 1-O-galloylquinic acid 162,76
344 3-O-galloylquinic acid
344 4-O-galloylquinic acid
344 5-O-galloylquinic acid
496 496 3,4-di-O-galloylquinic
acid
38,13
496 3,5-di-O-galloylquinic
acid
496 4,5-di-O-galloylquinic
acid
648 1,3,4-tri-O-galloylquinic
acid
648 648 1,3,5-tri-O-galloylquinic
acid
15,73
648 1,4,5-tri-O-galloylquinic
acid
648 3,4,5-tri-O-galloylquinic
acid
991 991 Pentagalloylglucose 7,43
322 322 Digallate 15,82
183 183 Methyl gallate 15,98
335 335 Methyl digallate 3,14
M/z ratio of C.spinosa reported compounds and compounds from the P2Et
fraction matching the m/z ratio. The relative abundance is expressed as % of
quercetin (internal standard)
Figure 2 Induction of morphological changes and cytotoxicity
in K562 cells by C. spinosa fractions without affecting normal
human cells. K562 (A, B, C), Fibroblasts (D), or PBMCs (E) cells were
treated with C.spinosa fractions at different concentrations for 48 h.
Morphological changes were evaluated by direct observation using
a light microscope at a magnification of 40X (B: 1. Ethanol; 2. S2Et;
3. P2Et; and 4. Etoposide). Cell cytotoxicity was estimated using the
MTT assay (C, D, and E). Ethanol and etoposide were used as
negative and positive controls, respectively. The results of six
experiments are shown.
Table 2 IC50 values of C.spinosa fractions and drugs in
tumor cell lines and normal cells (gingival fibroblasts and
PBMC) estimated using the MTT assay. *Concentration
(μg/ml) ± SE
Cell line/Treatment K562 Fibroblast PBMC
S2Et > 125* > 125* > 125*
P2Et 44.50* ± 4.05 64.30* ± 1.00 > 125*
Aqueous > 125* > 125* > 125*
Etoposide 15.60* ± 0.31 > 200* > 200*
Doxorubicin 0.24* ± 0.14 5.80* ± 0.40 2023* ± 0.50
Taxol 1.14* ± 0.15 - -
Vincristine 1.07* ± 0.28 0.07* ± 2.40 0.18* ± 2.00
Camptothecin 14.10* ± 3.70 - -
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Page 6 of 10Figure 3 P2Et fraction induction of MMP loss, activation of caspase 3 and DNA fragmentation. (A) K562 cells treated with the P2Et
fraction for 4, 8 or 12 h, stained with JC-1 and analyzed by flow cytometry. Ethanol was used as negative and valinomycin as positive controls
(*** p < 0.001). (B) Caspase 3 activity was measured using the enzyme-linked immunosorbent assay (ELISA) after cell treatment with the P2Et
fraction or doxorubicin (positive control) for 48 h (** p < 0.005). (C) PS externalization was estimated in K562 cells using flow cytometry after cell
treatment for 48 h with the P2Et fraction, doxorubicin (positive control) or ethanol (negative control). (D) DNA was stained with 4’,6-diamidino-2-
phenylindole (DAPI) after cell treatment for 48 h. Apoptotic cells or fragmented nuclei were observed under fluorescent microscope (40X). (E)
Apoptotic cells were estimated by random observation in six fields and by counting cells with strong fluorescence or fragmented nuclei.
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In order to determine if the P2Et fraction improves
tumor cell sensitivity to the conventional cancer drugs
doxorubicin, vincristine, camptothecin and taxol, a
dose-response test was used to choose sub-optimal
drugs and fraction concentrations as described in the
Methods section. Separately, doxorubicin or the P2Et
fraction at the tested concentrations showed a slight
effect on cell viability, but when used in combination a
significant decrease in cell viability was observed. In
contrast, when treatment with the P2Et fraction was
combined with vincristine or camptothecin, no positive
effect was identified (Figure 5A). Therefore, it is
worthwhile to point out that pretreatment with the
P2Et fraction may be enhancing the cytotoxicity of
taxol, highlighting a possible deleterious activity on
taxanes when combined with the polyphenol fraction.
On the contrary, in a similar analysis carried out on
the breast cancer cell line MCF7, the P2Et fraction did
exhibit adjuvant activity when combine with all the
tested drugs (doxorubicin, vincristine, taxol and camp-
tothecin, Figure 5B). Apoptotic cell death may not be
associated with treatment with the P2Et fraction, since
MMP loss and caspase 3 activity were not detected
(Figure 6A and 6B) nor PS externalization found (Fig-
ure 6C). Instead, a slight cell cycle arrest in the G1
phase was observed when the P2Et fraction and doxor-
ubicin treatments were combin e da tt w od i f f e r e n tc o n -
centrations (Figure 6D), unlike the results achieved
with the K562 cell line. The latter results suggest that
P2Et adjuvant activity depends on the type of antican-
cer drug and the cancer cell line.
The use of natural products as adjuvants in antitu-
mor therapy has been previously addressed; indeed,
EGCG, a condensate tannin present in green tea, has
been shown to sensitize cancer cells to taxol treatment
in a breast cancer model [22]. Also, it has been
reported that EGCG (at low doses) and epicatechin
gallate are not cytotoxic to a chemoresistant hepatocel-
lular carcinoma, but in combination with doxorubicin,
tumor cells were sensitized and a decrease in tumor
size was seen in vivo using a doxorubicin-resistant
liver cancer model [23]. The C. spinosa fraction that
was enriched in gallotannins not only exhibited cyto-
toxic activity, but also activity associated with conven-
tional anti-cancer drugs, demonstrating once again the
efficiency of natural products as potential sources of
adjuvants that can be used in antitumor therapy.
Herein, we described a C.spinosa derived fraction,
P2Et, that was relatively easy to produce and which
offered high yields in the extraction procedures; and
preliminary cytotoxicity studies suggest that it can be
used at very low dosages. In studies using several other
cell lines (data not shown) a wide range of activities
may be foreseen. Currently, the in vivo antitumor
activity of the P2Et fraction is being evaluated and che-
mical characterization is being completed so that the
molecular interactions may be scrutinized; and so that
the cell death mechanism and the sensitization exerted
by this fraction can be elucidated.
Figure 4 Abrogation of clonogenic activity in K562 cells by the
P2Et fraction. Cells were treated with the P2Et fraction, ethanol as
negative control and etoposide as positive control. Data represents
the mean number of colonies ± SE of 3 independent experiments.
***(p < 0.001) versus control.
Figure 5 Adjuvant activity of the P2Et fraction on the K562
and MCF7 cell lines. K562 (A) or MCF7 (B) cells were treated with
the P2Et fraction or ethanol (negative control) for 6 h, washed and
treated with doxorubicin (Dx), vincristine (Vt), camptothecin (Ct) or
taxol (Tx) at the concentrations shown over a 48 h period. Cell
cytotoxicity was estimated using the MTT assay. Data represent
three independent experiments. *** (p < 0.001).
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Page 8 of 10Figure 6 Induction of G1 cell cycle arrest but not apoptotic cell death in MCF7 cells by the P2Et fraction. (A) MCF7 cells treated with the
P2Et fraction for 6, 12 or 24 h, stained with JC-1 and analyzed by flow cytometry. Ethanol was used as negative and valinomycin as positive
controls (*** p < 0.001). (B) Caspase 3 activity was measured using the ELISA assay after cells had been treated with the P2Et fraction or
doxorubicin (positive control) for 48 h (** p < 0.005). (C) PS externalization was estimated in MCF7 cells using flow cytometry after treatment
with the P2Et fraction, doxorubicin (positive control) or ethanol (negative control) for 48 h. (D) Cell cycle analysis was performed on MCF7 cells
treated with ethanol (negative control), the P2Et fraction (7.80 μg/ml (A)), doxorubicin (0.004 μg/ml (B) or 0.002 μg/ml (C)), the P2Et fraction (A)
+ doxorubicin (B or C) and vincristine (0.01 μg/ml, positive control) for 24 h. The cells were permeabilized, stained with propidium iodide (PI),
acquired on a FACSAria I and analyzed with FLowJo software. Histograms represent relative cell DNA content measured in three independent
experiments.
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Page 9 of 10Conclusions
Our results suggest that the therapeutic efficacy of con-
ventional chemotherapeutic drugs when combined with
a blend of natural polyphenols may be increased in rela-
tion to leukemia or breast cancer cells. However, the
molecular mechanisms underlying this activity have yet
to be explained and are currently under study at our
laboratory.
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